Previous Page  4 / 9 Next Page
Information
Show Menu
Previous Page 4 / 9 Next Page
Page Background

Page 17

Notes:

conferenceseries

.com

Volume 8

Journal of Gastrointestinal & Digestive System

Gastroenterology Congress 2018

August 06-07, 2018

August 06-07, 2018 Osaka, Japan

14

th

Annual Congress on

Gastroenterology & Hepatology

Hepatocarcinoma in Guatemala contrasting global epidemiology

Luis Fernando Sandoval Garcia and Manuel Antonio Gatica

Instituto Guatemalteco de Seguridad Social, Guatemala

G

uatemala has the highest incidence and mortality of Hepatocarcinoma (HCC) in Latin America and the Caribbean in

both sexes. This liver neoplasm is the 7

th

cause of cancer in Central America and the 2

nd

cause of incidence and cancer

mortality in Guatemala. There are many risk factors already identified in the indisputable, first place is cirrhosis, then HBV

(chronic and carrier), HCV, alcoholism, NAFLD, etc. Only about 10% of HCCs develop in non-cirrhotic livers. In every day

medical practice, we have seen an increase in non-cirrhosis HCC with no other traditional risk factors. It woke up our curiosity

and interest to characterize our hepatic cancer. It is an observational, retrospective and analytical study. All HCC attended at

IGSS in 2015-2016 were analyzed, researching for epidemiological data, focusing in differences between cirrhotic vs. non-

cirrhotic patients. Statistical analysis was performed with PSPP 2007. Categorical variables were presented with frequency and

percentages and analyzed by chi squared of homogeneity. Normality was tested with Kolmogorov-Smirnov test. Numerical

data were evaluated with t-student of independent samples. At relational level a bivariate study was made, then elevated to

multivariate level. Total of 53 HCC cases were found, 15 cirrhotic and 38 non-cirrhotic (71.69%). Comparing both groups,

there is no statistical difference between age, BMI, sex, family history of cancer, alcoholism, tobacco, diabetes mellitus, obesity,

HBV, HCV, AFP, mass diameter, nor treatment (surgery, TACE, radiofrequency and sorafenib). There is difference in jaundice,

ascites and encephalopathy, possibly due the same cirrhosis. It should be emphasized the importance of the high number of

HCC in apparently healthy livers, contrasting global epidemiology. Staring with this new revealing knowledge we must analyze

our medical approach to diagnose and manage HCC in Guatemala and look for our non-traditional risk factors.

Biography

Luis Fernando Sandoval Garcia has graduated in General Medicine from Universidad de San Carlos de Guatemala with a Master’s degree and Chief of Residents

in Internal Medicine at IGSS. He works as an Internal Medicine Attending Physician in the same institute and as Professor in Universidad Francisco Marroquin.

Locally he has published researches about gastric cancer, esophageal varices, cirrhosis and HCC. He has showed the first epidemiological formal evidence of the

non-cirrhotic HCC at IGSS, Guatemala.

lufesandoval@ufm.edu

Luis Fernando Sandoval Garcia et al., J Gastrointest Dig Syst 2018, Volume 8

DOI: 10.4172/2161-069X-C4-073